尿液蛋白质组学鉴定组织蛋白酶D为1型糖尿病中eGFR快速下降的生物标志物
本研究在四个1型糖尿病队列中嵌套病例对照研究,以靶向液相色谱-串联质谱检测20种蛋白的38个肽段,发现尿液组织蛋白酶D与eGFR快速下降相关,合并发现集与验证集的比值比为每标准差1.29(95%CI 1.07-1.55),并反映肾小管间质损伤。
要点
- 在1型糖尿病队列中,尿液组织蛋白酶D与eGFR快速下降相关,合并分析OR为每SD 1.29(95%CI 1.07-1.55)。
- 验证集中调整白蛋白尿后,组织蛋白酶D与eGFR下降的关联失去显著性。
- 尿液组织蛋白酶D与肾小管间质损伤相关,小鼠近端小管上皮细胞培养中AGE-BSA增加其活性。
核心结论
- 尿液组织蛋白酶D与1型糖尿病中eGFR快速下降相关,并反映肾小管间质损伤。
研究设计与样本
- 在四个1型糖尿病队列中嵌套病例对照研究,病例与对照分别按eGFR下降≥3和<1 mL/min/1.73 m2/年分类。
- 采用靶向液相色谱-串联质谱检测20种糖尿病肾病相关蛋白的38个肽段,并在互补人类队列和小鼠近端小管上皮细胞培养中进一步研究。
- 队列研究纳入1,270名参与者,中位随访8年。
主要发现
- 在发现集中,仅组织蛋白酶D肽段和蛋白在完全调整临床和实验室变量后仍显著。
- 在验证集中,组织蛋白酶D与eGFR下降的关联在最小调整模型中可重复,但调整白蛋白尿后失去显著性。
- 在发现集与验证集合并的荟萃分析中,组织蛋白酶D与eGFR快速下降关联的比值比为每标准差1.29(95%CI 1.07-1.55)。
- 在互补人类队列中,尿液组织蛋白酶D与肾小管间质损伤相关,肾小管间质组织蛋白酶D表达与皮质间质分数体积增加相关。
- 在小鼠近端小管上皮细胞培养中,晚期糖基化终产物-BSA增加组织蛋白酶D活性及炎症和肾小管损伤标志物,组织蛋白酶D siRNA进一步增加这些标志物。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Understanding mechanisms underlying rapid estimated glomerular filtration rate (eGFR) decline is important to predict and treat kidney disease in type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: We performed a case-control study nested within four T1D cohorts to identify urinary proteins associated with rapid eGFR decline. Case and control subjects were categorized based on eGFR decline ≥3 and <1 mL/min/1.73 m2/year, respectively. We used targeted liquid chromatography-tandem mass spectrometry to measure 38 peptides from 20 proteins implicated in diabetic kidney disease. Significant proteins were investigated in complementary human cohorts and in mouse proximal tubular epithelial cell cultures. RESULTS: The cohort study included 1,270 participants followed a median 8 years. In the discovery set, only cathepsin D peptide and protein were significant on full adjustment for clinical and laboratory variables. In the validation set, associations of cathepsin D with eGFR decline were replicated in minimally adjusted models but lost significance with adjustment for albuminuria. In a meta-analysis with combination of discovery and validation sets, the odds ratio for the association of cathepsin D with rapid eGFR decline was 1.29 per SD (95% CI 1.07-1.55). In complementary human cohorts, urine cathepsin D was associated with tubulointerstitial injury and tubulointerstitial cathepsin D expression was associated with increased cortical interstitial fractional volume. In mouse proximal tubular epithelial cell cultures, advanced glycation end product-BSA increased cathepsin D activity and inflammatory and tubular injury markers, which were further increased with cathepsin D siRNA. CONCLUSIONS: Urine cathepsin D is associated with rapid eGFR decline in T1D and reflects kidney tubulointerstitial injury.
引用
- Limonte CP, Valo E, Drel V, et al. Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes. Diabetes Care. 2022. PMID: 35377940. doi:10.2337/dc21-2204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。